↓ Skip to main content

A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents…

Overview of attention for article published in Frontiers in Psychiatry, August 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter
13 X users

Citations

dimensions_citation
11 Dimensions

Readers on

mendeley
67 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1
Published in
Frontiers in Psychiatry, August 2021
DOI 10.3389/fpsyt.2021.701729
Pubmed ID
Authors

Mara Parellada, Antonia San José Cáceres, Melanie Palmer, Richard Delorme, Emily J. H. Jones, Jeremy R. Parr, Evdokia Anagnostou, Declan G. M. Murphy, Eva Loth, Paul P. Wang, Tony Charman, Andre Strydom, Celso Arango

X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 67 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 10%
Researcher 6 9%
Student > Doctoral Student 4 6%
Student > Bachelor 4 6%
Lecturer 3 4%
Other 7 10%
Unknown 36 54%
Readers by discipline Count As %
Psychology 9 13%
Social Sciences 5 7%
Medicine and Dentistry 5 7%
Neuroscience 2 3%
Nursing and Health Professions 2 3%
Other 4 6%
Unknown 40 60%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 January 2022.
All research outputs
#6,613,465
of 25,909,281 outputs
Outputs from Frontiers in Psychiatry
#3,131
of 12,929 outputs
Outputs of similar age
#124,281
of 437,475 outputs
Outputs of similar age from Frontiers in Psychiatry
#144
of 617 outputs
Altmetric has tracked 25,909,281 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 12,929 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.3. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 437,475 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 617 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.